tert-Butyl 4-(((3-chloroquinoxalin-2-yl)oxy)methyl)piperidine-1-carboxylate

Catalog No. :
ACKFPQ271
CAS No. :
1261229-80-4
Molecular Formula :
C19H24ClN3O3
Molecular Weight :
377.87

IUPAC Name:tert-butyl 4-(((3-chloroquinoxalin-2-yl)oxy)methyl)piperidine-1-carboxylate

tert-Butyl 4-(((3-chloroquinoxalin-2-yl)oxy)methyl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$590.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(((3-chloroquinoxalin-2-yl)oxy)methyl)piperidine-1-carboxylate
IUPAC Nametert-butyl 4-(((3-chloroquinoxalin-2-yl)oxy)methyl)piperidine-1-carboxylate
Molecular FormulaC19H24ClN3O3
Molecular Weight377.87
SMILESO=C(N1CCC(COC2=NC3=CC=CC=C3N=C2Cl)CC1)OC(C)(C)C
InChI KeySAWNVLSLIJPFHA-UHFFFAOYSA-N
Synonym4-(3-Chloro-quinoxalin-2-yloxymethyl)-piperidine-1-carboxylic acid tert-butyl ester;1-Piperidinecarboxylic acid, 4-[[(3-chloro-2-quinoxalinyl)oxy]methyl]-, 1,1-dimethylethyl ester
CAS No.1261229-80-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACKFPQ271 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZSNQ129 route compound structure diagram
    ACZSNQ129123855-51-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKFPQ271 route product structure diagram
    ACKFPQ2711261229-80-4
Inquiry

2. ACKFPQ271 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZSNQ129 route compound structure diagram
    ACZSNQ129123855-51-6 In Stock
  2. Plus
  3. ACHVRZ804 route compound structure diagram
    ACHVRZ80435676-70-1 In Stock
  4. Then
  5. ACKFPQ271 route product structure diagram
    ACKFPQ2711261229-80-4
Inquiry

Comments (0)